Proteomic and transcriptomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 2, 2007, Pages 516-521

  Shibuya, Masahiko ^a,b   Okamoto, Haru ^a   Nozawa, Takehiro ^c   Utsumi, Jun ^d   Reddy, Venkat N ^e   Echizen, Hirotoshi ^b   Tanaka, Yasuhiko ^f   Iwata, Takeshi ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c AMR Incorporated   (Japan)

^d TORAY INDUSTRIES INC   (Japan)

^e UNIVERSITY OF MICHIGAN   (United States)

^f International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; C MYC BINDING PROTEIN; CELL EXTRACT; MYC PROTEIN; PLACENTA PROTEIN 5; PROTEIN MDM2; PROTEIN P21; RETINOBLASTOMA BINDING PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN L11; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; E2F3 PROTEIN, HUMAN; EYE PROTEIN; GLYCOPROTEIN; MYC PROTEIN, HUMAN; PROTEOME; RETINOBLASTOMA PROTEIN; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA ISOLATION; TANDEM MASS SPECTROMETRY; TRANSCRIPTION INITIATION; TRANSCRIPTOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; MASS SPECTROMETRY; METABOLISM; PIGMENT EPITHELIUM;

CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; E2F3 TRANSCRIPTION FACTOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EYE PROTEINS; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PIGMENT EPITHELIUM OF EYE; PROTEOME; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 33847743023     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0434     Document Type: Article

References (35)

1. Hughes BA, Gallemore RP, Miller SS. Transport mechanisms in the retinal pigment epithelium. In: Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithelium: Function and Disease. New York: Oxford University Press; 1998:103-134.
2. Haruta M. Embryonic stem cells: potential source for ocular repair. Semin Ophthalmol. 2005;20:17-23.
3. Tanaka Y, Utsumi J, Matsui M, et al. Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2. Invest Ophthalmol Vis Sci. 2004;45:245-252.
4. Chand HS, Foster DC, Kisiel W. Structure, function and biology of tissue factor pathway inhibitor-2. Thromb Haemost. 2005;94: 1122-1130.
5. Schmidt AE, Chand HS, Cascio D, et al. Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin: implications for KD1 specificity of inhibition. J Biol Chem. 2005;280:27832-27838.
6. Chand HS, Schmidt AE, Bajaj SP, et al. Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2. J Biol Chem. 2004;279:17500-17507.
7. Sprecher CA, Kisiel W, Mathewes S, et al. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci USA. 1994;91:3353-3357.
8. Yanamandra N, Kondraganti S, Gondi CS, et al. Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. Int J Cancer. 2005;115:998-1005.
9. Rollin J, Iochmann S, Blechet C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer. 2005;92:775-783.
10. Konduri SD, Srivenugopal KS, Yanamandra N. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene. 2003;22:4509-4516.
11. Santin AD, Zhan F, Bignotti E, et al. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. Virology. 2005;331:269-291.
12. Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene. 2005;24: 850-858.
13. Kast C, Wang M, Whiteway M. The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. J Biol Chem. 2003;278:6787-6794.
14. Shinoda E, Yui Y, Hattori R, et al. Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells. J Biol Chem. 1999;274:5379-5384.
15. Bahk SC, Lee SH, Jang JU, et al. Identification of crystallin family proteins in vitreous body in rat endotoxin-induced uveitis: involvement of crystallin truncation in uveitis pathogenesis. Proteomics. 2006;6:3436-3444.
16. Taira T, Maëda J, Onishi T, et al. AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC. Genes Cells. 1998;3:549-565.
17. West KA, Yan L, Shadrach K, et al. Protein database, human retinal pigment epithelium. Mol Cell Proteomics. 2003;2:37-49.
18. Cai H, Del Priore LV. Gene expression profile of cultured adult compared to immortalized human RPE. Mol Vis. 2006;12:1-14.
19. Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem. 2002;277:11617-11620.
20. Uchida C, Miwa S, Kitagawa K, et al. Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J. 2005;24:160-169.
21. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100:57-70.
22. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12:2245-2262.
23. Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 1998; 9:585-593.
24. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000;2:E65-E67.
25. Dou QP, Levin AH, Zhao S, Pardee AB. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 1993;53: 1493-1497.
26. Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA. 1974;71:1286-1290.
27. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-1512.
28. Krystof V, McNae IW, Walkinshaw MD. Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor. Cell Mol Life Sci. 2005;62:1763-1771.
29. Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem. 2004;279: 44475-44482.
30. Zhang Y, Wolf GW, Bhat K, et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003;23:8902-8912.
31. 18O labeling for comparative proteomics: application to cytokine/lipolysaccharide-treated human retinal pigment epithelium cell line. Mol Cell Proteomics. 2005;4:1550-1557.
32. Chao C, Saito S, Kang J. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 2000; 19:4967-4975.
33. Bai F, Matsui T, Ohtani-Fujita N, et al. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett. 1998;437:61-64.
34. Nyunoya T, Powers LS, Yarovinsky TO. Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. J Biol Chem. 2003;278:36099-360106.
35. Ortego J, Escribano J, Coca-Prados M. Gene expression of protease and protease inhibitors in the human ciliary epithelium and ODM-2 cells. Exp Eye Res. 1997;65:289-299.